🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To find a recommended combination dose of decitabine and venetoclax that ca...
Status
Recruiting
Location
University of Miami
Start Date
2024-08-29
Trial ID
NCT06445959
Treatments Being Tested
The goal of this project is to see if two new potential treatments (defacti...
Status
Recruiting
Location
Prince of Wales Hospital
Start Date
2022-12-14
Trial ID
NCT05636514
Treatments Being Tested
Primary: To determine the maximum tolerated dose and schedule of decitabin...
Status
Completed
Location
Washington University School of Medicine
Start Date
2009-12
Trial ID
NCT00986804
Treatments Being Tested
This is an international, multicenter, multi-arm, phase Ib, model-based dos...
Status
Active Not Recruiting
Location
Allegheny Health Network
Start Date
2022-02-02
Trial ID
NCT03240211
Treatments Being Tested
This is a phase I study with a primary objective of determining the recomme...
Status
Recruiting
Location
Froedtert Hospital & the Medical College of Wisconsin
Start Date
2025-01-10
Trial ID
NCT06502145
This is an open-label, single-arm, multi-center Phase II clinical trial eva...
Status
Not Yet Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2026-06-01
Trial ID
NCT07542912
Treatments Being Tested
Determinate safety and response rate of the association Deferasirox -Vitami...
Status
Unknown
Location
GENT
Start Date
2013-02
Trial ID
NCT01718366
Treatments Being Tested
The purpose of this research study is to test the safety of a new three dru...
Status
Active Not Recruiting
Location
Brigham and Women's Hospital
Start Date
2022-07-18
Trial ID
NCT05455294
Treatments Being Tested
This is a single-arm open-label phase 1 dose escalation/expansion trial ass...
Status
Enrolling By Invitation
Location
Holden Comprehensive Cancer Center
Start Date
2025-06-05
Trial ID
NCT06896110
Treatments Being Tested
Tuberculosis has been shown to make immune genes inaccessible and slows imm...
Status
Withdrawn
Location
Harris Health System - Ben Taub Hospital
Start Date
2022-10
Trial ID
NCT03941496
Treatments Being Tested